The management of cyclophosphamide-induced haematuria

BJU Int. 2010 Apr;105(7):908-12. doi: 10.1111/j.1464-410X.2009.09132.x. Epub 2010 Jan 19.

Abstract

Haemorrhagic cystitis is a frequent complication of treatment with cyclophosphamide. It remains a difficult clinical problem to treat, compounded by the frailty of patient. Furthermore, the preventative measures and treatments available for CP-induced haematuria have their own benefits and disadvantages.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Alkylating / adverse effects*
  • Cyclophosphamide / adverse effects*
  • Epidemiologic Methods
  • Hematuria / chemically induced
  • Hematuria / prevention & control*
  • Humans
  • Neoplasms / drug therapy

Substances

  • Antineoplastic Agents, Alkylating
  • Cyclophosphamide